Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
DCTH - Delcath Systems, Inc.
Market Cap 43.19M P/E - EPS this Y 28.20% Ern Qtrly Grth -
Income -45.01M Forward P/E -4.12 EPS next Y 53.70% 50D Avg Chg -33.00%
Sales 2.17M PEG -0.06 EPS past 5Y - 200D Avg Chg -15.00%
Dividend N/A Price/Book N/A EPS next 5Y 15.00% 52W High Chg -50.00%
Recommedations 1.80 Quick Ratio 2.91 Shares Outstanding 22.05M 52W Low Chg 71.00%
Insider Own 2.87% ROA -64.03% Shares Float 19.70M Beta 0.47
Inst Own 37.46% ROE -356.60% Shares Shorted/Prior 712.69K/768.73K Price 4.00
Gross Margin 67.62% Profit Margin - Avg. Volume 82,175 Target Price 18.00
Oper. Margin -2,432.26% Earnings Date Nov 13 Volume 144,930 Change -4.76%
Healthcare | Medical Devices | United States
About Delcath Systems, Inc.

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

Delcath Systems, Inc. News
11/15/23 Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/13/23 Delcath Systems Reports Third Quarter 2023 Results and Provides Business Update
11/06/23 Delcath Systems to Host Third Quarter 2023 Results Call
10/16/23 Delcath Systems Announces a Comparative Study of Chemosat and SIRT Published in the Journal Cancers
10/10/23 Delcath Systems to Participate in the Lytham Partners Fall 2023 Investor Conference
10/03/23 Delcath Systems to Participate at the Roth MKM 2023 Healthcare Opportunities Conference on October 12, 2023
09/14/23 These 2 “Strong Buy” Penny Stocks Could Soar to $17 (Or Higher), Say Analysts
09/11/23 A Retrospective Comparative Study of Chemosat and SIRT Presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Meeting
09/05/23 Delcath Systems to Participate at the H.C. Wainwright 25th Annual Investor Conference on September 12 and 13, 2023
09/01/23 Delcath Systems, Inc. Announces Additional $35 Million in Funding Tied to the FDA Approval of HEPZATO KIT™
08/29/23 Delcath Systems Announces an Independent Investigator Presentation at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Meeting
08/25/23 Insider Buys Additional US$51k In Delcath Systems Stock
08/14/23 Delcath Systems, Inc. Announces FDA Approval of HEPZATO KIT™ for the Treatment of Adult Patients with Unresectable Hepatic-Dominant Metastatic Uveal Melanoma
08/12/23 Delcath Systems, Inc.'s (NASDAQ:DCTH) Path To Profitability
08/09/23 Delcath Systems Reports Second Quarter 2023 Results and Provides Business Update
08/03/23 Delcath Systems to File Its Second Quarter 2023 10-Q the Week of August 7 and Expects to Host a Conference Call the Following Week
06/20/23 Delcath Systems Appoints Vojislav Vukovic as Chief Medical Officer
03:10 PM Delcath Systems Announces Sandra Pennell as Senior Vice President of Finance
05/12/23 Delcath Systems Provides Business Update and Reports Preliminary First Quarter 2023 Financial Results
05/09/23 Delcath Systems to Participate in the Lytham Partners Spring 2023 Investor Conference
DCTH Chatroom

User Image TheBioPump Posted - 10 hours ago

$DCTH give me $3+

User Image Zzzquil Posted - 11 hours ago

$DCTH strange action today. Something happening behind the scenes?

User Image mailman1961 Posted - 11 hours ago

$DCTH looks like that was a stop raid at 1PM. Ticker has some strength now. Let see if they are renegotiating the debt due next month. That would be great news.

User Image DinoMcnuggets Posted - 11 hours ago

$DCTH 500k share order just popped up on the sell all the way to 2.6. Thats pretty insane volume.

User Image Houseofsweeps Posted - 13 hours ago

$DCTH we got some life here with 0 volume 🤣 Is it January yet?

User Image shortburner Posted - 2 days ago

$DCTH I don't expect a big rally until Spring. You accumulate now... The money will be made in Spring if management produces. Then we got $6.00 to $10.00

User Image Zzzquil Posted - 2 days ago

$DCTH bios rallying while we're stuck here 😴

User Image DinoMcnuggets Posted - 2 days ago

$DCTH Added additional shares at 2.8

User Image Houseofsweeps Posted - 11/30/23

$DCTH I just bought more DCTH. I had a limit buy at 2.75 Have no problem averaging down These prices will be a steal in a couple months. Especially end of next year. Just have to have patience the science is there

User Image brunoq14 Posted - 11/30/23

$DCTH 52 week low is 2.25, so I'm keeping some powder dry.

User Image DinoMcnuggets Posted - 11/30/23

$DCTH Needs a high volume catalyst. 0 sellers, but also 0 buyers. Volume is anemic at this point.

User Image tickeron Posted - 11/29/23

How do you think the market will react to this? $DCTH entered a Downtrend because Momentum Indicator dropped below the 0 level. View odds of downtrend. https://srnk.us/go/4928334

User Image Zzzquil Posted - 11/29/23

$DCTH peeps still loading around here?

User Image mailman1961 Posted - 11/28/23

$DCTH Rosalind pounding the table on this - up to 9.9% beneficial ownership.

User Image cctranscripts Posted - 11/28/23

Rosalind Opportunities Fund I L.P. just provided an update on activist position in Delcath Syst https://www.conferencecalltranscripts.org/summary/?id=12745216 $DCTH

User Image DinoMcnuggets Posted - 11/28/23

$DCTH Bought back in today around 2.88. Looking for this to move toward the 50 day MA next. Still need cfo and ceo to buy before launch. Announcement of Jcode is another potential catalyst here.

User Image brunoq14 Posted - 11/28/23

$DCTH Uniformly bullish analysts and massive insider buying. Plus the likely success of the CHOPIN trial, making DCTH part of a recommended drug combo for uveal melanoma.

User Image roll_thedice Posted - 11/25/23

@andreasnewitsch $DCTH since May 2010 I call it Death Systems

User Image scottwiley Posted - 11/22/23

$DCTH finally accumulation and on increased volume. Best wishes for all

User Image DinoMcnuggets Posted - 11/22/23

$DCTH Out at 3.07 for now. Had to take profit was up a huge chunk. May look for another entry around 2.7-2.75 if it gets that low again.

User Image tickeron Posted - 11/22/23

Oh wow this is big! $DCTH The volume increased for one day, resulting in a record-breaking daily growth of 239% of the 65-Day Volume Moving Average. View odds of downtrend. https://srnk.us/go/4921868

User Image StockAutomatePro Posted - 11/21/23

$DCTH Good news for investors chart analysis shows upward momentum. We alerted the BUY signal at $2.53 and we were able to close this one with profit at $2.97 💖

User Image brunoq14 Posted - 11/21/23

$DCTH Nearly 3x average volume.

User Image MarketBeatInsiderTrades Posted - 11/21/23

Delcath Systems Director Rosalind Advisors, Inc. Buys $240,000.00 in $DCTH www.marketbeat.com/stocks/NASDAQ/DCTH/insider-trades/

User Image insiderbuyingselling Posted - 11/21/23

$DCTH new insider buying: 100000 shares. http://insiderbuyingselling.com/?t=DCTH

User Image Santanatrading Posted - 11/21/23

$DCTH lets see 3:30$ now 🚀🚀🚀

User Image Santanatrading Posted - 11/21/23

$DCTH lets goo!! 🚀

User Image mailman1961 Posted - 11/21/23

$DCTH Insiders buying left and right.

User Image fredster45 Posted - 11/21/23

$DCTH rosalind advisors bought 100k shares at2.4041

User Image cctranscripts Posted - 11/21/23

Delcath Systems director just picked up 100,000 shares https://www.conferencecalltranscripts.org/summary/?id=12727245 $DCTH

Analyst Ratings
Canaccord Genuity Buy Sep 7, 23
Roth MKM Buy Aug 16, 23
BTIG Buy Aug 16, 23
HC Wainwright & Co. Buy Aug 15, 23
Canaccord Genuity Buy Aug 15, 23
HC Wainwright & Co. Buy May 24, 23
Roth MKM Buy Mar 28, 23
HC Wainwright & Co. Buy Mar 28, 23
HC Wainwright & Co. Buy Aug 10, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Rosalind Advisors, Inc. Director Director Nov 17 Buy 2.4041 100,000 240,410 1,038,828 11/21/23
Pennell Sandra SVP of Finance, PFO.. SVP of Finance, PFO and PAO Nov 17 Buy 2.43 30,000 72,900 30,000 11/21/23
Vukovic Vojo Chief Medical Office.. Chief Medical Officer Nov 16 Buy 2.48 60,000 148,800 60,000 11/20/23
Purpura John Chief Operating Offi.. Chief Operating Officer Oct 13 Buy 3.44 14,505 49,897 41,526 10/17/23
Sylvester John Richard Director Director Aug 21 Buy 4.80 10,550 50,640 10,550 08/23/23
MICHEL GERARD J Chief Executive Offi.. Chief Executive Officer Mar 29 Buy 4.84 19,646 95,087 197,235 03/30/23
Rosalind Advisors, Inc. Director Director Dec 14 Buy 3.6178 15,215 55,045 459,315 12/16/22
SALAMON STEVEN A J Director Director Dec 14 Buy 3.6178 15,215 55,045 455,315 12/16/22
MICHEL GERARD J Chief Executive Offi.. Chief Executive Officer Dec 13 Buy 2.90 51,725 150,002 177,589 12/14/22
MICHEL GERARD J Chief Executive Offi.. Chief Executive Officer Jul 20 Buy 3.98 62,814 250,000 125,864 07/21/22
Purpura John Chief Operating Offi.. Chief Operating Officer May 16 Buy 4.61 3,300 15,213 27,021 05/18/22
SALAMON STEVEN A J Director Director May 13 Buy 5.027 5,000 25,135 440,100 05/16/22
SALAMON STEVEN A J Director Director May 12 Buy 4.904 6,000 29,424 29,424 05/13/22
Rosalind Advisors, Inc. Director Director Apr 19 Buy 6.25 1,600 10,000 433,100 04/21/22
SALAMON STEVEN A J Director Director Apr 19 Buy 6.25 1,600 10,000 429,100 04/20/22
Rosalind Advisors, Inc. Director Director Apr 18 Buy 6.3487 2,000 12,697 431,500 04/19/22
Aharon Gil Director Director Apr 18 Buy 6.3487 2,000 12,697 404,000 04/19/22
MICHEL GERARD J See Remarks See Remarks Apr 18 Buy 6.36 2,000 12,720 63,050 04/18/22
Rosalind Advisors, Inc. Director Director Apr 13 Buy 6.45 1,500 9,675 429,500 04/14/22
SALAMON STEVEN A J Director Director Apr 13 Buy 6.45 1,500 9,675 427,500 04/14/22
Rosalind Advisors, Inc. Director Director Apr 12 Buy 6.48 2,500 16,200 428,000 04/12/22
SALAMON STEVEN A J Director Director Apr 12 Buy 6.48 2,500 16,200 425,000 04/12/22
Rosalind Advisors, Inc. Director Director Apr 06 Buy 6.45 2,000 12,900 425,500 04/08/22